Smallpox vaccines: From first to second to third generation

Lancet

Volumn 365, Issue 9457, 2005, Pages 362-363

  Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; SMALLPOX VACCINE;

ANTIBODY TITER; CATTLE; CELL PROLIFERATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG CONTRAINDICATION; DRUG SAFETY; ECZEMA; ENZYME LINKED IMMUNOSPOT ASSAY; HEART INFARCTION; HUMAN; IMMUNOGENICITY; KERATITIS; LYMPH; NOTE; PERICARDITIS; PHYSICAL EXAMINATION; POSTVACCINAL ENCEPHALITIS; PRIORITY JOURNAL; SIDE EFFECT; SKIN DISEASE; SMALLPOX; T LYMPHOCYTE; TRANSIENT ISCHEMIC ATTACK; VACCINIA; VACCINIA VIRUS;

EID: 13144256724     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70209-9     Document Type: Note

References (5)

1. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med. 281:1969;1201-1208
2. Centers for Disease Control and Prevention. Update: adverse events following civilian smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep. 52:2003;475-477
3. Halsell JS, Riddle JR, Atwood JE, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 289:2003;3283-3289
4. Centers for Disease Contol and Prevention. Smallpox (vaccinia) vaccine contraindications. 2004: http://www.bt.cdc.gov/agent/smallpox/vaccination/ contraindications-clinic.asp (accessed Oct 1,2004).
5. Poland GA, Neff JM. Smallpox vaccines: problems and prospects. Poland GA. Immunology and allergy clinics of North America: vaccines in the 21st century. 2003;731-743 WB Saunders, Philadelphia